Fungal cell walls contain chitin (a linear polymer of N-acetylglucosamine) as a structural backbone, unlike bacterial peptidoglycan or plant cellulose. Additional polysaccharides like β-glucans and mannans provide strength and flexibility. Cell wall composition varies by fungal species and growth phase, affecting immune recognition and antifungal drug susceptibility.
You know from your study of carbohydrate structure that polysaccharides are long chains of sugar monomers linked by glycosidic bonds, and that the specific monomers and linkages determine a polymer's properties. You also know from fungal biology that fungi are eukaryotes — they have nuclei, mitochondria, and membrane-bound organelles like animal cells. Yet fungi are enclosed in a rigid cell wall, which animal cells lack. The composition of that wall is what distinguishes fungi from both bacteria and plants, and understanding it is key to both antifungal therapy and immune recognition.
The structural backbone of the fungal cell wall is chitin, a linear polymer of N-acetylglucosamine (GlcNAc) residues linked by β-1,4 glycosidic bonds. If this monomer sounds familiar, it should — N-acetylglucosamine is also a component of bacterial peptidoglycan. But while peptidoglycan alternates GlcNAc with N-acetylmuramic acid and cross-links the chains with short peptide bridges, chitin is a pure homopolymer with no peptide cross-links. The result is a tough, insoluble fibrillar network — the same material that forms insect exoskeletons and crustacean shells. Chitin microfibrils provide tensile strength, preventing the fungal cell from bursting under osmotic pressure.
Layered over and around the chitin scaffold are β-glucans — polymers of glucose linked primarily by β-1,3 and β-1,6 bonds. β-1,3-glucans form a gel-like matrix that fills spaces between chitin fibrils, providing structural integrity and elasticity. The outermost layer consists of mannans (polymers of mannose) and mannoproteins — heavily glycosylated proteins that project from the cell surface. These outer mannoproteins determine many of the fungal cell's interactions with its environment, including adhesion to host tissues and recognition by the immune system. The innate immune receptor Dectin-1 specifically recognizes β-1,3-glucans, while mannose receptors detect the outer mannan layer. This is why cell wall composition directly determines how the immune system detects and responds to fungal infection.
The clinical relevance is direct. Because animal cells have no cell walls, the fungal wall is an ideal drug target — it allows selective toxicity analogous to how antibiotics target bacterial peptidoglycan. Echinocandins (like caspofungin) inhibit the enzyme β-1,3-glucan synthase, collapsing the structural matrix and causing osmotic lysis. Echinocandins have no effect on human cells because we do not synthesize glucans. Cell wall composition also varies between fungal species and growth forms — *Candida* yeast cells, hyphae, and biofilms differ in their wall architecture, which affects both immune evasion and drug susceptibility. Understanding the layered polysaccharide structure of the fungal wall is therefore foundational for both mycology and antifungal pharmacology.